SOX2, OCT3/4 and NANOG expression and cellular plasticity in rare human somatic cells requires CD73.
SOX2, OCT3/4 and NANOG expression and cellular plasticity in rare human somatic cells requires CD73.
复制标题
稀有人类体细胞中 SOX2、OCT3/4 和 NANOG 的表达和细胞可塑性需要 CD73。
DOI:
10.1016/j.cellsig.2016.09.008
复制
发表时间:
2016
影响因子:
4.8
通讯作者:
Tlsty,TheaD
中科院分区:
文献类型:
--
作者:
Pan,Deng;Roy,Somdutta;Gascard,Philippe;Zhao,Jianxin;Chen-Tanyolac,Chira;Tlsty,TheaD
Endogenous Plastic Somatic (ePS) cells isolated from adult human tissues exhibit extensive lineage plasticityin vitroandin vivo. Here we visualize these rare ePS cells in a latent state,i.e.lacking SOX2, OCT3/4 and NANOG (SON) expression, in non-diseased breast specimens through immunohistochemical analysis of previously identified ePS-specific biomarkers (CD73+, EpCAM+and CD90−). We also report a novel mechanism by which these latent ePS cells acquire SON expression and plasticityin vitro. Four extracellular factors are necessary for the acquisition of SON expression and lineage plasticity in ePS cells: adenosine (which is produced by the 5′ ecto-nucleotidase CD73 and activates in turn the PKA-dependent IL6/STAT3 pathway through the adenosine receptor ADORA2b), IL6, FGF2 and ACTIVIN A. Blocking any pathway component renders ePS cells incapable of SON expression and lineage plasticity. Notably, hESCs do not use adenosine or IL6 nor they express CD73 or ADORA2b and inhibition of adenosine signaling does not ablate their plasticity. Therefore, the data presented here delineate novel circuitry and physiological signals for accessing SON expression in rare, undifferentiated human cells.